FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and chemical technology. What is offered is a method for producing the peptide Exenatide. The peptide Exenatide prepared by synthesis may be used for producing drugs for type 2 diabetes mellitus.
EFFECT: higher yield of the unpurified peptide (42%-60%), as well as higher purity (58%-75%) and content of the end product in a mixture (33%-42%); besides, a cheaper condensing agent (DIC) is used at all the condensation stages, while the synthesis of more than one short fragments simultaneously enables faster end peptide process.
3 cl, 2 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE FOR MEDICAL TREATMENT OF PANCREATIC DIABETES OF 2ND TYPE AND ITS COMPLICATIONS | 2014 |
|
RU2573933C1 |
| GLP-1 PEPTIDE HAVING ATTACHED OLIGOSACCHARIDE CHAIN | 2008 |
|
RU2539829C2 |
| EXENATIDE ANALOGUE | 2020 |
|
RU2823623C1 |
| PROCESS FOR PREPARATION OF GLYCOPEPTIDE HAVING SIALYLATED SUGAR CHAIN, AND METHOD FOR PRODUCING SIALYL GLYCOASPARAGINE | 2012 |
|
RU2586524C2 |
| METHOD FOR PRODUCING PEPTIDES CONTAINING LIPOPHILICALLY MODIFIED LYSINE SIDE CHAIN | 2017 |
|
RU2755543C2 |
| METHOD OF PRODUCING PEPTIDE | 2008 |
|
RU2478105C2 |
| SITE-SPECIFIC MONOPHYLATED ANALYGES OF EXCENDIN AND THE METHOD OF THEIR PRODUCTION | 2012 |
|
RU2625015C2 |
| GLP-1 ANALOGUE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND THEREOF APPLICATION | 2010 |
|
RU2565536C2 |
| ANALGESIC AGENT OF PEPTIDE STRUCTURE OF UNDERCAPEPTIDE CONTAINING D-OCTAARGININE VECTOR | 2013 |
|
RU2541127C1 |
| GLYCATED PEPTIDE GLP-1 | 2009 |
|
RU2543157C2 |
